Live-attenuated hepatitis A virus vaccine (Zhejiang Pukang Biotechnology)

冻干甲型肝炎减毒活疫苗（浙江普康）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive-attenuated hepatitis A virus vaccine (Zhejiang Pukang Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis A
Global Approved IndicationsHepatitis A
Approved Indications in ChinaHepatitis A
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhejiang Pukang Biologic Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Pukang Biologic Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis A
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC02
Related LinksWikipedia